What is it? Why is it important?

Routine Monitoring Visit(s) (RMV) are carried out after the Site Initiation Visit (SIV) and until the end of the study, or the end of participant recruitment.

 

During RMVs, the monitor gains an overview of study progress and site compliance. This is important in order to ensure that:

What do I need to do?

If you are the study monitor, make applicable arrangements to prepare for an upcoming RMV:

  • Arrange a date for the RMV with the study site
  • Based on the IMP/IMD, provide a list of documents to be reviewed
  • Ensure access to electronic records (e.g. study eCRF, ISF, relevant medical records such as the patient file)
  • Estimate the time needed to complete your monitoring tasks
  • Ensure that all study personnel are available for support during the RMV

 

Extent of study monitoring during RMVs is determined by the MP.

 

Request any necessary access to electronic records at the study site ahead of time, because it may take time to arrange required access rights. If local access cannot be granted, obtain applicable Source Data (SD) or any other necessary information in printed form.

More

During on-site monitoring visits, many different documents must be handled simultaneously. As a Site-INV provide the monitor with a personal work desk on the day of the visit in order to facilitate his or her work, and the management of all study relevant documents.

Where can I get help?

Your local Research Support Centre can assist you with experienced staff regarding this topic

  • Basel, Departement Klinische Forschung (DKF), dkf.unibas.ch

  • Lugano, Clinical Trials Unit (CTU-EOC), ctueoc.ch

  • Bern, Department of Clinical Research (DCR), dcr.unibe.ch

  • Geneva, Clinical Research Center (CRC), crc.hug.ch

  • Lausanne, Clinical Research Center (CRC), chuv.ch

  • St. Gallen, Clinical Trials Unit (CTU), h-och.ch

  • Zürich, Clinical Trials Center (CTC), usz.ch

References

ICH GCP E6(R2) – see in particular guidelines

  • 4.5 Protocol Compliance
  • 5.18 Monitoring activities
  • 6.10 Access to source data / documents

ISO 14155 Medical Device – see in particular section (access liable to costs)

  • 9.2.4 Monitoring

ISO 20916 – In Vitro Diagnostica (access liable to costs)

ISO 20387 – Biobanking (access liable to costs)

Swiss Law

HRA – see in particular

  • Art. 1 Purpose

ClinO – see in particular article

  • Art. 5 Good Clinical Practice

ClinO-MD – see in particular

  • Art. 3 Applicable provisions

HRO  – see in particular

  • Art. 2 Applicable provisions
Abbreviations
  • ClinO – Clinical Trials Ordinance
  • ClinO-MD – Ordinance on Clinical Trials of Medical Device
  • eCRF – electronic Case Report Form
  • CTU – Clinical Trials Unit
  • FADP – Federal Act on Data Protection
  • GCP – Good Clinical Practice
  • HRO – Human Research Ordinance
  • ICH GCP – International Council for Harmonisation Good Clinical Practice
  • ISF –Investigator Site File
  • ISO – International Organisation for Standardisation
  • MP – Monitoring Plan
  • SD – Source Data
  • Site-INV – Site Investigator
  • SIV – Site Initiation Visit
  • RMV – Routine Monitoring Visit
Conduct ↦ Monitoring ↦ Routine Monitoring Visit ↦ Preparation
Study
Basic

Provides some background knowledge and basic definitions

Basic Monitoring
Basic Drug or Device
Concept

Starts with a study idea

Ends after having assessed and evaluated study feasibility

Concept Statistic Methodology
Concept Drug or Device
Development

Starts with confidence that the study is feasible

Ends after having received ethics and regulatory approval

Development Drug or Device
Set-Up

Starts with ethics and regulatory approval

Ends after successful study initiation

Set-Up Ethics and Laws
Set-Up Statistic Methodology
Set-Up Quality and Risk
Set-Up Drug or Device
Conduct

Starts with participant recruitment

Ends after the last participant has completed the last study visit

Conduct Statistic Methodology
Conduct Drug or Device
Completion

Starts with last study visit completed

Ends after study publication and archiving

Completion Drug or Device
Current Path (click to copy): Conduct ↦ Monitoring ↦ Routine Monitoring Visit ↦ Preparation

Please note: the Easy-GCS tool is currently under construction.